228 News & Informationen zur Novavax, Inc. Aktie

  • US-Börse: Wall Street: Raus aus Nasdaq-Index und rein in den Dow
    stern.de

    US-Börse: Wall Street: Raus aus Nasdaq-Index und rein in den Dow

    New York – Das Muster der vergangenen Tage am US-Aktienmarkt hat sich am Freitag wiederholt: Ein erneut starker Renditeanstieg am Anleihemarkt brachte

  • Novavax bestätigt hohe Wirksamkeit gegen Original- und Variant-COVID-19-Stämme in Studien in Großbritannien und Südafrika
    prnewswire.com

    Novavax bestätigt hohe Wirksamkeit gegen Original- und Variant-COVID-19-Stämme in Studien in Großbritannien und Südafrika

    /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), ein Biotechnologie-Unternehmen, das Impfstoffe der nächsten Generation gegen schwere Infektionskrankheiten…

  • Why Novavax Could Become a Latecomer Leader in the COVID Vaccine Race
    fool.com

    Why Novavax Could Become a Latecomer Leader in the COVID Vaccine Race

    This small biotech could be like the tortoise in Aesop's famous fable.

  • Novavax (NVAX) Dips More Than Broader Markets: What You Should Know
    zacks.com

    Novavax (NVAX) Dips More Than Broader Markets: What You Should Know

    In the latest trading session, Novavax (NVAX) closed at $127.43, marking a -1.96% move from the previous day.

  • Novavax bosses cash out for $46 mil with COVID-19 vaccine trials still under way
    japantoday.com

    Novavax bosses cash out for $46 mil with COVID-19 vaccine trials still under way

    Top executives at U.S. pharmaceutical company Novavax Inc aren't waiting to see how well their COVID-19 vaccine works before they reap the financial rewards. Chief Executive Stanley Erck and three of his top lieutenants have sold roughly $46 million of company stock since the start of last year, according to…

  • Novavax Hires Regulatory Expert As Coronavirus Vaccine Inches Closer To Emergency Use Filing
    benzinga.com

    Novavax Hires Regulatory Expert As Coronavirus Vaccine Inches Closer To Emergency Use Filing

    Novavax, Inc. (NASDAQ: NVAX) is beefing up its executive team as it prepares to release results of its late-stage coronavirus vaccine study and file for …

  • Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer
    investorideas.com

  • Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer, Business News
    asiaone.com

    Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer, Business News

    Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer

    GlobeNewswire

    January 15, 2021

    GAITHERSBURG, Md., Jan. 15, 2021 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the appointment of Henrietta Ukwu, M.D., FACP, FRAPS, to the position…

  • Pfizer Leads Vaccine Stocks As The Most Trusted Name In Covid-19: IBD/TIPP
    investors.com

    Pfizer Leads Vaccine Stocks As The Most Trusted Name In Covid-19: IBD/TIPP

    A growing number of Americans are willing to get a coronavirus vaccine, according to the latest IBD/TIPP Poll. That could help vaccine stocks.

  • Novavax Will Likely Do Well Once Its Covid-19 Vaccine Trials Come Out
    investorplace.com

    Novavax Will Likely Do Well Once Its Covid-19 Vaccine Trials Come Out

    NVAX stock is poised for returns once its Phase 3 trial results come out, but potential investors should keep their eyes on the news.

  • What’s Happening With Novavax Stock?
    forbes.com

    What’s Happening With Novavax Stock?

    Vaccine developer Novavax (NASDAQ: NVAX) is seen as a key player in the Coronavirus vaccine space. Here’s a quick overview of what has been happening with the company over the last few weeks. Firstly, Novavax initiated a phase 3 study for its Covid-19 vaccine candidate in the U.S. and Mexico…

  • My Best Coronavirus Stock for 2021
    fool.com

  • What’s Happening With Moderna Stock?
    forbes.com

    What’s Happening With Moderna Stock?

    Moderna (NASDAQ: MRNA) stock rose by about 4% over the last week to levels of around $113 per share. Here’s a quick rundown of the developments for the company over the last week. Firstly, Moderna raised the low-end of its global production estimate for its vaccine from 500 million doses to 600…

  • Is the Options Market Predicting a Spike in Novavax (NVAX) Stock?
    zacks.com

    Is the Options Market Predicting a Spike in Novavax (NVAX) Stock?

    Investors need to pay close attention to Novavax (NVAX) stock based on the movements in the options market lately.

  • 2 Investing Mistakes to Avoid Like the Plague in 2021
    fool.com

  • Why Novavax Fell by Over 4% Today
    fool.com

    Why Novavax Fell by Over 4% Today

    Investors seem perturbed by some reporting about top managers' recent financial moves.

  • Why Novavax Stock Is Bound for Massive Gains in 2021
    investorplace.com

    Why Novavax Stock Is Bound for Massive Gains in 2021

    Novavax lost the race to be first with a Covid-19 vaccine, but NVX-CoV2373 is nearing approval. It will boost NVAX stock in 2021.

  • My Best Coronavirus Vaccine Stock for 2021
    fool.com

  • 3 Top Biotech Picks for 2021
    fool.com

    3 Top Biotech Picks for 2021

    One big biotech and two small biotechs that share a common denominator: Great growth prospects.

  • Novavax Strikes Another Coronavirus Vaccine Supply Deal: Where Does The Company's Program Stand?
    benzinga.com

    Novavax Strikes Another Coronavirus Vaccine Supply Deal: Where Does The Company's Program Stand?

    Novavax, Inc. (NASDAQ: NVAX) shares are higher Friday following a coronavirus vaccine supply deal the company announced with the Australian government.
    Deal …

  • 3 Low Forward Price-Earnings Ratio Stock Picks
    gurufocus.com

    3 Low Forward Price-Earnings Ratio Stock Picks

    3 Low Forward Price-Earnings Ratio Stock Picks, Stocks: MRK,ABBV,NVAX, release date:Jan 08, 2021

  • Biotech Stock News: Novavax (NASDAQ: NVAX) Finalizes Agreement with Commonwealth of Australia for 51 Million Doses of COVID-19 Vaccine
    investorideas.com

    Biotech Stock News: Novavax (NASDAQ: NVAX) Finalizes Agreement with Commonwealth of Australia for 51 Million Doses of COVID-19 Vaccine

  • The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs
    benzinga.com

    The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs

    Here's a roundup of top developments in the biotech space over the last 24 hours.
    Scaling The Peaks
    (Biotech Stocks Hitting 52-week Highs Jan. 7) …

  • New Year's Resolutions And COVID-19 Vaccine Doses
    valuewalk.com

    New Year’s Resolutions And COVID-19 Vaccine Doses

    Although roughly only 4 million doses of the COVID-19 vaccine have been administered to date (after a 20 million goal), the government has

  • 3 Things to Expect from Novavax in 2021
    fool.com

  • 2021 Could Be Novavax's Year
    benzinga.com

    2021 Could Be Novavax’s Year

    Novavax (NASDAQ: NVAX) saw its stock gain over 3,000% last year. But it could have even more room to run as the market will get only crazier for vaccines …

  • Biotech Stock News: Novavax (NASDAQ: NVAX) to Participate in Upcoming Conferences
    investorideas.com

  • Novavax to Participate in Upcoming Conferences
    benzinga.com

    Novavax to Participate in Upcoming Conferences

    GAITHERSBURG, Md., Jan. 06, 2021 (GLOBE NEWSWIRE) — Novavax, Inc. (NASDAQ:NVAX), a late-stage biotechnology company developing next-generation vaccines for …

  • Why Did Novavax Stock Decline 20% In December?
    forbes.com

    Why Did Novavax Stock Decline 20% In December?

    Vaccine specialist Novavax – which is seen as a key player in the Covid-19 vaccine space – saw its stock price decline by about 20% over December. Here are a few possible reasons for the decline. Covid-19 vaccines by Pfizer and Moderna received emergency approval from the U.S. FDA in December…

  • The Worst Mistake Novavax Investors Can Make Right Now
    fool.com

    The Worst Mistake Novavax Investors Can Make Right Now

    Investors will soon have data to judge management’s big projections.

  • New Year's Resolutions and Vaccine Distributions
    gurufocus.com

    New Year’s Resolutions and Vaccine Distributions

    New Year’s Resolutions and Vaccine Distributions, Stocks: SNOW,ABNB,DASH,AMZN,NFLX,DASH,ZM,PFE,MRNA,JNJ,AZN, release date:Jan 04, 2021

  • New Year's Resolutions and Vaccine Distributions
    gurufocus.com

    New Year’s Resolutions and Vaccine Distributions

    New Year’s Resolutions and Vaccine Distributions, Stocks: SNOW,ABNB,DASH,AMZN,NFLX,DASH,ZM,PFE,MRNA,JNJ,AZN, release date:Jan 04, 2021

  • 5 Best Health Care Stocks to Buy in 2021
    moneycrashers.com

    5 Best Health Care Stocks to Buy in 2021

    The health care sector a massive opportunity for investors – more than 10% of GDP is spent on it. Here are several intriguing picks to consider.

  • 5 Best Biotech Stocks to Buy in 2021
    moneycrashers.com

    5 Best Biotech Stocks to Buy in 2021

    Are you looking to add biotech stocks to your portfolio? We’ve found the best stocks that are leaders in the industry and not overpriced.

  • December 2020 Market Wrap: Modest Gains After A Huge Year. What's Next?
    investing.com

    December 2020 Market Wrap: Modest Gains After A Huge Year. What’s Next?

    Stocks Analysis by Investing.com (Charley Blaine/Investing.com) covering: Nasdaq 100, XAU/USD, XAG/USD, S&P 500. Read Investing.com (Charley Blaine/Investing.com)’s latest article on Investing.com

  • 3 coronavirus stocks poised to soar in 2021
    fool.com.au

  • 5 Top Penny Stock Picks In 2020 Traders Watched Explode To New Highs
    pennystocks.com

  • 3 Coronavirus Stocks Poised to Soar in 2021
    fool.com

  • 3 Healthcare Stocks That Turned $100,000 Into $1 Million in 2020
    fool.com

    3 Healthcare Stocks That Turned $100,000 Into $1 Million in 2020

    These clinical-stage drug developers were unstoppable last year.

  • These Were the 3 Best Coronavirus Stocks of 2020
    fool.com

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Entdecke die 6 ETFs in denen Novavax, Inc. am höchsten gewichtet ist Insgesamt in 32 ETFs enthalten

Dir gefallen die Informationen zu Novavax, Inc.?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Novavax, Inc.?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Novavax, Inc.?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Novavax, Inc.?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero